A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.
Also called NCT06622772
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 212 participants
- Sponsor
- Registry
-
NCT06622772
-
- Other papers using this trial's data
- Device-Assisted vs Standard Valsalva Maneuver for Terminating Supraventricular Tachycardia: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06622772. Randomized; no masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2023-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia
- Condition
- Supraventricular Tachycardia (SVT)
- Intervention (Device)
- Valsalva assist device
- Intervention (Other)
- standard Valsalva manoeuvre
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct06622772- Content hash
83969dc14dc43b475574d723294bf953667f64a0c55be01f2284467090af61ed